04:34 PM EDT, 07/29/2024 (MT Newswires) -- Symbotic ( SYM ) reported a fiscal Q3 loss Monday of $0.02 per diluted share, narrower than a loss of $0.07 a year earlier. Analysts polled by Capital IQ expected breakeven. Revenue in the quarter ended June 29 rose to $491.8 million from $311.8 million a year earlier. Analysts surveyed by Capital IQ...

04:33 PM EDT, 07/29/2024 (MT Newswires) -- Robert Qutub, Executive Vice President, Chief Financial Officer, on July 26, 2024, sold 2,500 shares in Renaissancere Holdings ( RNR/PF ) for $561,400. Following the Form 4 filing with the SEC, Qutub has control over a total of 73,915 shares of the company, with 73,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/913144/000091314424000100/xslF345X03/wk-form4_1722284904.xml Price: 226.94,...

July 29 (Reuters) - Sanofi-owned biotech company Genzyme has sued rival Sarepta Therapeutics ( SRPT ) in Delaware federal court for allegedly infringing two patents related to Sarepta's Duchenne muscular dystrophy (DMD) treatment Elevidys. Genzyme said in the lawsuit, made public on Monday, that Sarepta mimics Genzyme's technology for modifying viruses used to deliver genes into human cells in gene-therapy...

04:31 PM EDT, 07/29/2024 (MT Newswires) -- Element Solutions ( ESI ) reported Q2 adjusted earnings late Monday of $0.36 per share, up from $0.31 a year earlier. Analysts surveyed by Capital IQ expected $0.35. Net sales in the quarter ended June 30 rose to $612.7 million from $586.1 million a year earlier. Analysts surveyed by Capital IQ expected $608.3...